Achillion: Down But Not Out And Progress Being Made
Seeking Alpha
This Week in Biotech
Motley Fool
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
3 Horrendous Health-Care Stocks This Week
Motley Fool
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
- AbbVie
- Achillion
- Aegerion
- Amarin
- Arena Pharmaceuticals
- AstraZeneca
- Aveo Pharmaceutical
- Biogen Idec
- Bristol-Myers Squibb
- Delcath
- Dendreon
- Depomed
- Gilead
- GSK
- Merck
- NewLink Genetics
- Raptor Pharmaceuticals
- Rigel
- Sangamo BioSciences
- Sucampo
- Titan Pharmaceuticals
- Valeant Pharmaceuticals
- Vertex Pharmaceuticals
- Vivus
- Zogenix
Hepatitis C In Play for 2013?
Motley Fool
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
13 Biotech Stock Predictions for 2013
TheStreet.com